|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 31/18 | (2006.01) |
| (11) | Number of the document | 2552963 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11711554.3 |
| Date of filing the European patent application | 2011-03-30 | |
| (97) | Date of publication of the European application | 2013-02-06 |
| (45) | Date of publication and mention of the grant of the patent | 2014-03-26 |
| (46) | Date of publication of the claims translation | 2014-07-25 |
| (86) | Number | PCT/EP2011/054945 |
| Date | 2011-03-30 |
| (87) | Number | WO 2011/121040 |
| Date | 2011-10-06 |
| (30) | Number | Date | Country code |
| 749891 | 2010-03-30 | US | |
| 10290167 | 2010-03-30 | EP |
| (72) |
KLINGUER-HAMOUR, Christine, FR
JOUHANNEAUD, Alexandra, FR
GRENIER-CAUSSANEL, Véronique, FR
BERGER, Sven, FR
|
| (73) |
Pierre Fabre Médicament,
45, Place Abel Gance, 92100 Boulogne-Billancourt,
FR
|
| (74) |
Leonas Antanas KUČINSKAS,
Dr. Leono A. Kučinsko patentinių paslaugų firma, Kaštonų g. 5-7, LT-01107 Vilnius,
LT
|
| (54) | Humanizuoti anti-CXCR4 antikūnai, skirti vėžio gydymui |
| HUMANIZED ANTI CXCR4 ANTIBODIES FOR THE TREATMENT OF CANCER |
| Payment date | Validity (years) | Amount | |
| 2016-03-01 | 6 | 139.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2017-03-30 |